Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer

INTRODUCTION: Small-cell lung cancer (SCLC) accounts for 15% of all lung cancers and has been understudied for novel therapies. Signaling through fibroblast growth factors (FGF2, FGF9) and their high-affinity receptor has recently emerged as a contributing factor in the pathogenesis and progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liping, Yu, Hui, Badzio, Andrzej, Boyle, Theresa A., Schildhaus, Hans-Ulrich, Lu, Xian, Dziadziuszko, Rafal, Jassem, Jacek, Varella-Garcia, Marileila, Heasley, Lynn E., Kowalewski, Ashley A., Ellison, Kim, Chen, Gang, Zhou, Caicun, Hirsch, Fred R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467588/
https://www.ncbi.nlm.nih.gov/pubmed/26020126
http://dx.doi.org/10.1097/JTO.0000000000000562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467588/
https://www.ncbi.nlm.nih.gov/pubmed/26020126
http://dx.doi.org/10.1097/JTO.0000000000000562

Ejemplares similares